Professional Documents
Culture Documents
UG102GE-T UG202GE-T: 46 - 500 033 040-23680 000 25 Web: WWW - Braou.ac - in
UG102GE-T UG202GE-T: 46 - 500 033 040-23680 000 25 Web: WWW - Braou.ac - in
UG102GE-T UG202GE-T: 46 - 500 033 040-23680 000 25 Web: WWW - Braou.ac - in
-
-
I
-
-
- II
46
- 500 033
040-23680 00025 Web: www.braou.ac.in
I
(C)
O.U.
II
III
V
- I
1
3
4
(Paleolithic) (Old Stone Age)
(lower),(midle)(upper)
(Fire)
(Eoliths)
(Food gatherer)
5
(core) (flakes)
(flame industry)
(core industry)
(Neanderthal)
(Mammoth) (Rhinoceros)
(alluvial sand)
(surplus)
6
(Farming Technology)
(Tundras)(Steppes)
(Adge)
(innovation).
(social unit)
(Metal Age) (Chalcolithic Age)
7
(dark period)
(Minerals)
(Solar calender)
(standards)
(Metallurgy)
(Alloy)
(Bronze)
8
(Wheel)
(Carpentry)
(Symmetrical Character)
(Quantity)
(balance)
(Theoretical Astronomy)
(Cosmology)
9
(writing)(Urban
revolution)
(Principles)
(Theoritical Science)
(pre-history)
10
11
(solistices)
(equinoxes)
12
13
16
17
18
I
II
19
20
21
22
24
(Horizon)
25
26
28
10000C
60000C
(Corona)
29
P, S
Fe, Mg
P,S
30
‘S’
‘P’
(Ni-Fe)
31
O3 O2
(signals)
O
32
polar ice cap
un habitable zones
(6 mi) 33
C
0
34
I
II
35
36
37
i E
Ohm
iE
i = KE
38
K I/R “R”
E=iR
(Primary)(Secondary).
Zn + 2NH4 Cl + 2MnO4 ZnCl2 + Mn2 O3 (s) + 2NH3 + H2O
Pb2+ PbO2
Pb (s) + PbO2 (s) + 2H2 So4 2 Pb SO4 (s) +2 H2O
39
‘n’‘p’
n p
(emitter)(base)
‘pn’ v
In, B, Al ‘p’As, Sb, p
‘n’ n-p
(H)
(He) H+H He+
40
(Rain Bow)
“VIBGYOR”
41
(Wave)
42 f/2, f/28, f/4, f/56, f/6,
f/11, f/16
(magnification)
LASER
Light Amplication by Stimmulated Emission of Radiation
43
(Coherence)
44
N-S S-N
45
(Si)(Ge)
46 (Doped)
p n
p n p-n
A-CD-C
p-n p
p n
NOTANDOR
XOR
NAND 11 NAND
NAAD
47
48
49
I
II
51
52
53
H2,O2,N2,Cl2
P2,As4,Sb4) O3)
H2 , O2 , O3 , P4 , S3
HCl
CO2
NH3
H2 O
54
Cl, Na, Mg, S, Ca, K, C. Br, B, Sr, Si, N, Li, Al,
Rb
(Na, Cl) (H,O)
55
(M) (M+)
56
(Hg) Zn-Hg, Cd-Hg
Zn
90 - Cu - 10 - Al
70 - Cu - 30 - Zn
75-Cu-25-Sn+0
Zn, Al
80-Cu-20-Sn
88-Sn,Sb-7,Cu-4
40 Nl, 60-Cu
95.5 Al, 4-Cu
0.5-Mg, 0.5-Mn
Cn, Zn
95-Mg, 5-Zn
+Al,Cu,Zn
50-Cu,25-Zn,25-Nl
88-Cu,10-Sn,2-Zn
90-Al,10-Mg
67-Sn,33-Pb
+11-Cr,+7- Nl
82-Pb,15-Sb,3-Sn
12.5 - Cd, 50-Bl
57
(CaCO3)
1500 0 C
CaO-50-55%, Si O3 - 20 - 25% Al2 O3 - 5- 10%
(KNO3)
59
NH4 CNO NH2 CO NH4
OH, CHO, CO, COOH
(CH4)
60
-OH CH3 OH
-CHO CH3 CHO
>CO CH3 COCH3
>COOH CH3 COOH
- COOR CH3 COOC2 H5
-CO NH2 CH3 CONH2
- CO Cl CH3 COCl
- NH2 CH3 NH2
- NO2 CH3 NO2
-O- CH3 OCH3
- Cl CH3 Cl
CH Cl3
CH3 CH2 CH2 CH2 CH2 CH2 CHO
C6H5 C HO
CH3 - CH2 - CH3
CH3 - CH = CH2
CH3 - C CH
CH2-CH2
CH CH CH2 - CH3
CH2-CH2 HC-CH
61
(PVC)
62
63
(PVC)
64
65
I
II
-OH, -CHO > CO-COOH
PVC
66
- II
67
68
69
70
71
DOTS
72
73
Epidemic Diseases
Host population
DEN1,
DEN2, DEN4
SIV S-01V
H1N1, H1N2, H2N1, H3 N1, H2N3
74
RcH (RcH)
75
STDs
VD(RTI)
PID
AIDS
HIV
77
ELISA
PCR
i
ii
iii.
IUD IUCD
IUD
‘T’ CU
CUT CUCU 250 / CUT 380
iii) IUD
i
78
CDRI
(ii)
DMPA NETEN
(iii)
morning - after
II. Terminal
Essuure
79
scrotum
ducts
80
AI
IUI
suurrogacy
Assisted Reproductive Technologies
IVE - ET
U.K.
ICSI
81
ZIFTI
IUT
GIFT
AI
ZIFT
IUT
82
83
A
A
A
B
B1
B2
B3
B5
B6
B7
B12
C
D
E
84
A
A
A
B
B1
B2
B3
85
B5
B6
B7
B12
C
D
E
86
(PHC)
87
I
II
88
89
90
(Cornea)
(Immu-
nological reaction)
P
P
P
P
P depolarization
QRSQRcoplex
SRORScomplex
pericardical ffusioninfiltrative
T QRS
TLVH 93
T
Myocardial infrac-
tion
ELISA
EIA
Anti bodyAntigen
ELISAHIV
HIVserum
ELISA
94
95
PSA
PSACA-125
AFP
***
DPT & OPV
98
99
100
MRI, EEG, ECG, ELISA
I
II
101
102
103
Host
sp
106
107
DNA
GMO
VIT-A
i)ii)iii)iv)v)
vi) CRISPLR vii) TALEN.
108
Husbandary
109
Silver Revolution
C PDP
FCR
CPDO
NDDBEEC
110
EEC
111
FAO
HACCP
112
BHA, 113
BHI
114
pH
pH
115
HYV
116
I
II
117
DNA
118
ICT
ICT
T.V.ICT
ICT e- e-
e- ICT
LPG
RTC
ICT ICT
ICT
ICT
121
(DAE)
DAE
(INCoSPAR)
INCOSPARDAE(ISRO)
(DOS)
DOS
DOSISRO
ISRO
(VSSC) ISRO (ISAC)
SHAR
(SAC)
VSSC
(RS-I)
APPLE
122
PSLV
PSLV
m
m 123
PSLV
GSLV I &II. -II
49
m G.T.O.
m
S L GS2
GS3
GSLV kg GSAT-1
GSLV-D2 (GSAT-2 1825 Kg) GSLV-F01, (EDUSAT
1950 kg) GSLV Fo2 GSLV-FO4 INSAT-4CR 2130 KgGSLV-D3-
GSLV-Fob-
124
IRS (Indian Remote Sensing Agency)
C C
125
ISRO
(DSN)
(Impactor) PSLV-
XL (C11) 06:22 IST
00.2UTC
126
127
synthetic
somatic embrigos
Integumarts
desiccation
(ii)
Tissue culture
128
i)
(Immunity)
iii
á (INF- á)â (INF- â) 129
T Ò (INF- Ò)
iv
DNA
HGH(TPA)
EPO VIII.
DNA
130
10-9m
DNA
EPA
131
self aasambled
(counter - puts)
132
(Three
dimensional)
(Coverging Pechndagnes)
(Cognitive)
(bottom-up)
i)
134
NSSC
NASA
i) (Drug delivery)
135
ii)
iii)
(staph)
iv
staph
staph
136
I.TI.C.T
INSAT-1A (1982), INSAT 1B (1983), INSAT 1 (1988)
HGHTPAEPO
137
I
II
ICT
138
139
(i ii iii iv
i ii iii iv
i ii iii iv
i ii iii iv
i ii iii iv
i ii iii iv
i ii iii iv
i ii
iii iv
140